|
|
|
|
|
|
Postdoctoral Fellows
|
| Name | | Training Period | | Research Focus |
| Joel Depper, M.D. | | 1981-1984 | | IL-2 Receptor Regulation |
| Warren Leonard, M.D. | | 1981-1984 | | Molecular Analysis of IL-2R |
| Martin Kronke, M.D. | | 1982-1984 | | Analysis of HTLV-I Tax |
| Mitch Dukovich, Ph.D. | | 1984-1988 | | High Affinity IL-2R Assembly |
| Miriam Siekevitz, Ph.D. | | 1985-1988 | | Action of Cyclosporin A in Regulation of IL-2 Gene Expression |
| Yuji Wano, M.D. | | 1985-1988 | | High Affinity IL-2R Assembly |
| Ernst Bohnlein, Ph.D. | | 1987-1989 | | Analysis of NF-kB |
| Laurence Rimsky, Ph.D. | | 1987-1990 | | Analysis of HTLV-I Rex |
| Dean Ballard, Ph.D. | | 1987-1992 | | Analysis of NF-kB/Rel |
| Peter Kaufman, M.D. | | 1987-1991 | | NF-kB Expression in Monocytes |
| Marion Fung, Ph.D. | | 1988-1991 | | Molecular Cloning of IL-2Rg |
| Sarah Hanly, Ph.D. | | 1988-1991 | | HTLV-I Rex and HIV-1 Rev |
| Jerome Kim, M.D. | | 1988-1991 | | Analysis of HTLV-II Rex |
| Naomuchi Arima, M.D. | | 1989-1992 | | IL-2 Signaling |
| Mark A. Goldsmith, M.D., Ph.D. | | 1992-1993 | | IL-2R Assembly and Signaling |
| Shao-Cong Sun, Ph.D. | | 1992-1994 | | Analysis of IkBa |
| Christophe Beraud, Ph.D. | | 1992-1996 | | Analysis of HTLV-I Tax |
| Michael Miller, Ph.D. | | 1992-1997 | | Analysis of HIV Nef |
| Romas Geleziunas, Ph.D. | | 1993-2000 | | Analysis of HIV Nef |
| Doug Powell, Ph.D. | | 1993-1997 | | Analysis of HIV Nef |
| Teri Liegler, Ph.D. | | 1993-1997 | | HIV and T-Cell Apoptosis |
| Carlos de Noronha, Sc.D. | | 1994-2004 | | Analysis of Vpr and G2 Cell Cycle Arrest |
| Sarah Gaffen, Ph.D. | | 1994-1996 | | IL-2 Receptor Signaling |
| Akifumi Takaori-Kondo, M.D., Ph.D. | | 1995-1996 | | HIV Vpr and G2 Cell Cycle Arrest |
| Xin Lin, Ph.D. | | 1995-2000 | | Analysis of NF-kB Signaling |
| Emmett Cunningham, M.D., Ph.D. | | 1996-1997 | | CD28 Signaling for NF-kB Induction |
| Yonchu Jenkins, Ph.D. | | 1996-1998 | | HIV Vpr Nuclear Import |
| Li Lin, Ph.D. | | 1996-2000 | | NF-kB p105 Processing |
| Patricia Bresnahan, Ph.D. | | 1996-1999 | | HIV Nef and CD4 down-regulation |
| Marina Heusch, Ph.D. | | 1997-1999 | | NF-kB p100 Processing |
| Michael Sherman, M.D., Ph.D. | | 1997-2002 | | HIV Vpr |
| Alison O'Mahony, Ph.D. | | 1997-2005 | | NF-kB in the Brain and Roles of IKK1 & IKK2 in NF-kB Activation by HTLV-I Tax |
| Erik Foehr, Ph.D. | | 1998-2001 | | NF-kB in the Brain |
| Jan Bohuslav, Ph.D. | | 1999-2005 | | Interplay of NF-kB and p53 Relating to Cell Cycle and Apoptosis |
| Lin-feng Chen, Ph.D. | | 1999-2005 | | NF-kB Subunit RelA Regulation by Reversible Acetylation |
| Jorge Ochoa-Garay, M.D., Ph.D. | | 2000-2002 | | NF-kB p100/p105 Shuttling |
| Marielle Cavrois, Ph.D. | | 2000-present | | HIV-1 Particle Fusion with Primary Cells Utilizing a Novel Virion-based Fusion Assay |
| Hakju Kwon, Ph.D. | | 2000-2005 | | HTLV-I Tax And T-Cell Transformation |
| David Fenard, Ph.D, | | 2001-2004 | | Mechanism of Nef Action on T-cell Signaling Pathways |
| Vanessa Soros, Ph.D. | | 2002-2007 | | Role of Vpr in Macrophage Infection by HIV-1 |
| Andreas Jekle, Ph.D. | | 2002-2003 | | Mechanism of HIV-1 Bystander Cell Killing in Lymphoid Histoculture |
| Sabine Thebault, Ph.D. | | 2002-2003 | | Regulation of HDAC3-mediated Deacetylation of RelA |
| Akihito Yonezawa, M.D., Ph.D. | | 2002-2005 | | Molecular Basis for HIV Pathogenesis and Ebola Virus Entry Using Pseudotyped HIV |
| Gilad Doitsh, Ph.D. | | 2003-present | | Investigation of the mechanism of bystander killing in HIV infected lymphoid cultures |
| Ya-Lin Chiu, Ph.D. | | 2003-2008 | | Exploring the complexities of APOBEC3G complexes |
| Carmen Martin, Ph.D. | | 2004-2006 | | Molecular mechanisms of HIV post-integration latency |
| Mario Santiago, Ph.D. | | 2005-2009 | | Determinants of HIV-1 restriction by the A3G complex |
| Samuel Williams, Ph.D. | | 2006-2/2007 | | Vpr signal transduction |
| Jonathan Chan, Ph.D. | | 2006-present | | Regulation of RelA transactivation function by post-translational modification |
| Silke Wissing, Ph.D. | | 2006-present | | Exploring the differences between mitogen stimulation and cytokine stimulation of CD8+ T cells for the biological assembly of HMM APOBEC3G complexes |
| Ronda Bransteitter, Ph.D. | | 2006-2007 | | HIV-1 Vif Interactions with APOBEC3G |
| Kimberly Stopak, Ph.D. | | 1/2007-4/2007 | | Function of Vif In HIV
Infection |
| Andrew Hebbeler, Ph.D. | | 2007-2009 | | APOBEC and HIV Latency |
| Nadia Roan, Ph.D. | | 2007-present | | Characterizing Host Factors that Influence Male-to-Female Transmission of HIV |
| David Lim, M.D., Ph.D. | | 2007-present | | APOBEC3 in HIV-1 Elite Suppressors |
| Kara Lassen, Ph.D. | | 2008-present | | Mechanisms of HIV Latency |
| Zhiyuan Yang, Ph.D. | | 2008-present | | Investigation of the postentry restriction of HIV by APOBEC3 proteins |
| Stefanie Sowinski, Ph.D. | | 2009-present | | TBD |
|
|
|
|
|
| | |
